Needle-free injection technologies have been developed for injecting drugs and vaccines in a solid and liquid dosage form. Needle-free injection systems helps to introduce various medicines into patients without piercing the skin with a conventional needle. Hypodermic needles, which are being used these days were first introduced during the 1800s, whereas needle-free systems are relatively recent inventions. This technology is beneficial for the pharma industry and developing countries too for using it during mass immunization programs, bypassing the chances of needle stick injuries and avoiding other complications that arise due to multiple uses of a single needle. Needle-free drug delivery devices avoid infections which are an effective solution for getting contamination. This technology is being backed by organizations such as the World Health Organization, Centers for Disease Control and Prevention and various groups including Bill and Melinda Gates Foundation. An increase in the number of diabetic patients is likely to stimulate the demand for these devices. Rising pressure to reduce the rate of infectious diseases such as hepatitis, dengue fever, neurological disorders, and AIDS is deriving the demand of Needle-free injection. The Needle-Free Drug Delivery Technology Market valued USD 8.7 billion in 2020 and it is expected to reach USD 23.9 billion by 2030 with the CAGR of 10.6% during the forecast period.

Market Segmentation:

Global needle-free drug delivery technology market is segmented by type of working like spring systems, laser-powered, and energy propelled systems further subcategorized into Lorentz force, gas propelled/air force, and Shock waves. The market is divided by the type of load that is liquid, powder, and projectile. The market is divided by drug delivery type by nano-patches further classified into sandpaper assisted delivery, Iontophoresis enabled, and micro-needles. By the site of delivery, the market is categorized into intradermal injectors, intramuscular injectors, and subcutaneous injectors. By application, the needle-free drug delivery technology market can be segmented into vaccine delivery, insulin delivery, and pain management. By categorized into end-user type by hospitals & clinics, home care settings, and research laboratories. By geography the needle-free drug delivery technology market is segmented into North America, APAC, Europe, and the RoW. 

Market Dynamics and Factors:

Surging demand and technological advancements in the field of pain-free drug transportation and self-administration have been playing an instrumental role in driving the market. Rising pressure to control the incidence rate of infectious diseases such as hepatitis, dengue fever, neurological disorders, and AIDS caused by the West Nile virus during transmission is estimated to boost the growth of the needle-free drug delivery technology market. Changing regulatory requirements and lack of skilled professionals may restrict the growth of the needle-free drug delivery technology market. The high number of diabetes ridden population is expected to act as a major driver for the market growth due to the requirement of insulin delivery devices that are pain-free, and needle-free. Limitations and drawbacks associated with the devices like, blockage and restrictions of the flow of drugs are expected to slow down the market growth. The high cost of these devices is also expected to hinder the needle-free drug delivery technology market growth.

Geographic Analysis:

The global needle-free drug delivery technology market is expected to rise from USD 8.15 billion by 2018 to an estimated value of USD 17.42 billion by 2026, registering an approximate CAGR of 9.95% in the forecast period of 2016-2026. North America followed by Europe are the two largest markets for needle-free drug delivery technology at present and they are expected to account for a large proportion of the needle-free drug delivery technology market in the forecast period as well. This is due to the high presence of the chronic and acute diseases in the region, the ongoing research & development initiatives for the treatment options and the increasing demand for technologically advanced drug delivery systems for better outcomes. High awareness regarding the potential benefits of needle-free drug delivery devices has supported the dominance of the region in the global arena. Asia Pacific market is anticipated to witness lucrative growth over the forecast year owing to the rising prevalence of diabetes in developing countries such as India and China. For instance, the International Diabetes Federation states that in 2017, India had about 7.2 billion individuals suffering from diabetes and China had about 11.4 billion individuals suffering from diabetes.

Competitive Scenario:

The major/Key market players operating in the needle-free drug delivery technology market are Antares Pharma, 3M, Injex Pharma AG, Verdict Media Limited; Pharmajet; Zonenix; Inovio Pharmaceuticals, Inc., Valeritas, Inc., Penjet, PharmaJet, Bioject Medical Technologies Inc., and Endo Pharmaceuticals Inc.

Needle-Free Drug Delivery Technology Market Report Scope